Industry: Pharmaceuticals, Biotechnology
ImmuneRegen BioSciences, Inc., a wholly owned subsidiary of IR BioSciences Holdings, Inc. (BULLETIN BOARD: IRBO), is a biotechnology company engaged in the research and development of applications utilizing modified Substance P, a naturally occurring immunomodulator. Derived from homeostatic substance P, the company has named their proprietary compound “Homspera.” The Company’s initial focus is on the continuing development of Homspera for various applications for use in improving pulmonary function and stimulating the human immune system. ( www.immuneregen.com )
ImmuneRegen BioSciences , Inc.
4021 N. 75Th Street Suite 201
Scottsdale, Arizona 85251
USA
Tel: (310) 477-9500
Fax: (480) 222-3295